Patents Assigned to CV Theraeputics, Inc.
  • C-pyrazole A2A receptor agonists
    Patent number: 6855818
    Abstract: 2-adenosine C-pyrazole compositions having the following formula: and methods for using the compositions as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: February 15, 2005
    Assignee: CV Theraeputics, Inc.
    Inventors: Jeff A. Zablocki, Venkata P. Palle, Elfatih O. Elzein